BEAM
Price
$26.07
Change
+$1.54 (+6.28%)
Updated
Jan 22, 04:01 PM (EDT)
Capitalization
2.03B
41 days until earnings call
SEER
Price
$2.38
Change
+$0.02 (+0.85%)
Updated
Jan 22, 10:54 AM (EDT)
Capitalization
139.16M
36 days until earnings call
Ad is loading...

BEAM vs SEER

Header iconBEAM vs SEER Comparison
Open Charts BEAM vs SEERBanner chart's image
Beam Therapeutics
Price$26.07
Change+$1.54 (+6.28%)
Volume$1.65K
Capitalization2.03B
Seer
Price$2.38
Change+$0.02 (+0.85%)
Volume$100
Capitalization139.16M
BEAM vs SEER Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. SEER commentary
Jan 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and SEER is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 22, 2025
Stock price -- (BEAM: $24.53 vs. SEER: $2.36)
Brand notoriety: BEAM and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 69% vs. SEER: 82%
Market capitalization -- BEAM: $2.03B vs. SEER: $139.16M
BEAM [@Biotechnology] is valued at $2.03B. SEER’s [@Biotechnology] market capitalization is $139.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $341.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, SEER is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while SEER’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 3 bearish.
  • SEER’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than SEER.

Price Growth

BEAM (@Biotechnology) experienced а +5.28% price change this week, while SEER (@Biotechnology) price change was +3.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +1.94%, and the average quarterly price growth was -2.90%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

SEER is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.03B) has a higher market cap than SEER($139M). SEER YTD gains are higher at: 2.165 vs. BEAM (-1.089). SEER has higher annual earnings (EBITDA): -92.7M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. SEER (248M). SEER has less debt than BEAM: SEER (26.5M) vs BEAM (162M). BEAM has higher revenues than SEER: BEAM (350M) vs SEER (14.2M).
BEAMSEERBEAM / SEER
Capitalization2.03B139M1,461%
EBITDA-160.83M-92.7M173%
Gain YTD-1.0892.165-50%
P/E RatioN/AN/A-
Revenue350M14.2M2,465%
Total Cash926M248M373%
Total Debt162M26.5M611%
TECHNICAL ANALYSIS
Technical Analysis
BEAMSEER
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 15 days ago
82%
Bearish Trend 15 days ago
90%
Momentum
ODDS (%)
Bearish Trend 15 days ago
89%
Bullish Trend 15 days ago
88%
MACD
ODDS (%)
Bearish Trend 15 days ago
86%
Bullish Trend 15 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 15 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 15 days ago
83%
Bearish Trend 15 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 20 days ago
77%
Declines
ODDS (%)
Bearish Trend 21 days ago
85%
Bearish Trend 28 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 15 days ago
74%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 15 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSWWX25.430.31
+1.23%
Loomis Sayles Global Allocation Y
BACAX13.84N/A
N/A
BlackRock Energy Opportunities Inv A
GHTMX12.50N/A
N/A
Goldman Sachs International T/M Eq Instl
JUEZX24.85N/A
N/A
JPMorgan US Equity R2
HRLCX8.24N/A
N/A
Hartford Real Asset C

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+4.65%
CRSP - BEAM
71%
Closely correlated
+2.42%
NTLA - BEAM
62%
Loosely correlated
+4.63%
DNLI - BEAM
60%
Loosely correlated
+5.06%
PRME - BEAM
60%
Loosely correlated
+0.69%
RXRX - BEAM
59%
Loosely correlated
+5.36%
More

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
+3.06%
AXON - SEER
56%
Loosely correlated
+1.97%
ARRY - SEER
47%
Loosely correlated
-4.62%
PMVP - SEER
41%
Loosely correlated
-1.46%
DNLI - SEER
37%
Loosely correlated
+5.06%
BEAM - SEER
37%
Loosely correlated
+4.65%
More